<qa>  What is the name of the PHARMACOKINETICS of ABT-335?SAFETY STUDY TO EVALUATE THE EFFECTS OF MILD AND MODERATE RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF ABT-335 AND ROSUVASTATIN WHEN ADMINISTERED CONCOMITANTLY: 